Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells

  • Lee, Guinevere Q.
  • Orlova-Fink, Nina
  • Einkauf, Kevin
  • Chowdhury, Fatema Z.
  • Sun, Xiaoming
  • Harrington, Sean
  • Kuo, Hsiao-Hsuan
  • Hua, Stephane
  • Chen, Hsiao-Rong
  • Ouyang, Zhengyu
  • Reddy, Kavidha
  • Dong, Krista
  • Ndung’u, Thumbi
  • Walker, Bruce D.
  • Rosenberg, Eric S.
  • Yu, Xu G.
  • Lichterfeld, Mathias
Journal of Clinical Investigation 127(7):p 2689-2696, June 30, 2017. | DOI: 10.1172/JCI93289

HIV-1 causes a chronic, incurable disease due to its persistence in CD4+ T cells that contain replication-competent provirus, but exhibit little or no active viral gene expression and effectively resist combination antiretroviral therapy (cART). These latently infected T cells represent an extremely small proportion of all circulating CD4+ T cells but possess a remarkable long-term stability and typically persist throughout life, for reasons that are not fully understood. Here we performed massive single-genome, near-full-length next-generation sequencing of HIV-1 DNA derived from unfractionated peripheral blood mononuclear cells, ex vivo-isolated CD4+ T cells, and subsets of functionally polarized memory CD4+ T cells. This approach identified multiple sets of independent, near-full-length proviral sequences from cART-treated individuals that were completely identical, consistent with clonal expansion of CD4+ T cells harboring intact HIV-1. Intact, near-full-genome HIV-1 DNA sequences that were derived from such clonally expanded CD4+ T cells constituted 62% of all analyzed genome-intact sequences in memory CD4 T cells, were preferentially observed in Th1-polarized cells, were longitudinally detected over a duration of up to 5 years, and were fully replication- and infection-competent. Together, these data suggest that clonal proliferation of Th1-polarized CD4+ T cells encoding for intact HIV-1 represents a driving force for stabilizing the pool of latently infected CD4+ T cells.

Copyright © 2017 The American Society for Clinical Investigation, Inc.